FI
CVAC

Fosun International’s CureVac CVAC Stock Holding History

Fosun International’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,000
Closed -$290K – 101
2022
Q1 		$290K Buy
15,000
+5,000
+50% +$99.8K 0.03% 183
2021
Q4 		$337K Buy
+10,000
New +$402K 0.02% 190
2021
Q2 		– Sell
-50,000
Closed -$4.44M – 215
2021
Q1 		$4.44M Buy
+50,000
New +$4.85M 0.35% 45

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Fosun International's CVAC Position: Q2 2022 in Review

Fosun International sold out of CureVac (CVAC) in Q2 2022, closing a stake of 15,000 shares — an estimated $290K sold.

Fosun International first reported a position in CVAC in Q1 2021 and held it in 3 quarters. The position peaked at $4.44M in Q1 2021. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2022.

  • Fosun International reported no remaining CureVac position as of Q2 2022 after selling out during the quarter.
  • Fosun International sold 15,000 CureVac shares in Q2 2022, an estimated $290K.
  • Fosun International first reported a position in CureVac in Q1 2021 and held it in 3 quarters.
  • Fosun International's CureVac position peaked at $4.44M in Q1 2021.
  • 88 funds tracked by Wall St. Rank held CureVac as of Q2 2022.

Based on Fosun International's 13F filing for Q2 2022, filed 10 Aug 2022.